Literature DB >> 21999942

Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study.

Masaru Nakayama1, Yoriko Ura, Masaharu Nagata, Yasushi Okada, Yoko Sumida, Kanako Nishida, Hirofumi Ikeda, Yoshiki Kaizu.   

Abstract

BACKGROUND: Vascular calcification has been recognized as a risk factor for cardiovascular (CV) events in patients with end-stage renal disease (ESRD). However, the association of carotid artery calcification (CAAC) with CV events remains unknown. The aim of this study was to elucidate whether CAAC is associated with composite CV events in ESRD patients.
METHODS: One-hundred thirty-three patients who had been started on hemodialysis between 2004 and 2008 were included in this retrospective cohort study. These patients received multi-detector computed tomography to assess CAAC at the initiation of hemodialysis. Composite CV events, including ischemic heart disease, heart failure, cerebrovascular diseases, and CV deaths after the initiation of hemodialysis, were examined in each patient.
RESULTS: CAAC was found in 94 patients (71%). At the end of follow-up, composite CV events were seen in 47 patients: ischemic heart disease in 20, heart failure in 8, cerebrovascular disease in 12, and CV deaths in 7. The incidence of CAAC was 87% in patients with CV events, which was significantly higher than the rate (62%) in those without. Kaplan-Meier analysis showed a significant increase in composite CV events in patients with CAAC compared with those without CAAC (p = 0.001, log-rank test). Univariate analysis using a Cox hazards model showed that age, smoking, common carotid artery intima-media thickness and CAAC were risk factors for composite CV events. In multivariate analysis, only CAAC was a significant risk factor for composite CV events (hazard ratio, 2.85; 95% confidence interval, 1.18-8.00; p = 0.02).
CONCLUSIONS: CAAC is an independent risk factor for CV events in ESRD patients. The assessment of CAAC at the initiation of hemodialysis is useful for predicting the prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 21999942      PMCID: PMC3206830          DOI: 10.1186/1471-2369-12-56

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  41 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients.

Authors:  Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

3.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

4.  Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.

Authors:  U Schwarz; M Buzello; E Ritz; G Stein; G Raabe; G Wiest; G Mall; K Amann
Journal:  Nephrol Dial Transplant       Date:  2000-02       Impact factor: 5.992

5.  Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis.

Authors:  Masahiko Tozawa; Kunitoshi Iseki; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

6.  Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins.

Authors:  Sharon M Moe; Kalisha D O'Neill; Danxia Duan; Sadiq Ahmed; Neal X Chen; Stephen B Leapman; Naomi Fineberg; Kenyon Kopecky
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

7.  Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.

Authors:  T Haraki; T Takegoshi; C Kitoh; K Kajinami; T Wakasugi; J Hirai; T Shimada; M Kawashiri; A Inazu; J Koizumi; H Mabuchi
Journal:  Clin Nephrol       Date:  2001-08       Impact factor: 0.975

8.  Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.

Authors:  Francis Verbeke; Wim Van Biesen; Eero Honkanen; Björn Wikström; Per Bruno Jensen; Jean-Marie Krzesinski; Merete Rasmussen; Raymond Vanholder; Pieter L Rensma
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 8.237

9.  Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.

Authors:  Yoshiki Nishizawa; Tetsuo Shoji; Kiyoshi Maekawa; Kyoko Nagasue; Senji Okuno; Masao Kim; Masanori Emoto; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

10.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  8 in total

1.  Presepsin Level Correlates with the Development of Moderate Coronary Artery Calcifications in Hemodialysis Patients: A Preliminary Cross-Section Design Study.

Authors:  Ahmed F Elhabashi; Leena Sulaibeekh; Nahed Seddiq; Salman Alali; Amjad K Abdulmajeed; Nuria S Perez
Journal:  Risk Manag Healthc Policy       Date:  2020-08-03

2.  Carotid artery Doppler ultrasonography in patients with chronic kidney disease.

Authors:  Ismail Salk; Gursel Yildiz; Hulusi Egilmez; Mehmet Haydar Atalar; Ferhan Candan; Ali Cetin
Journal:  Med Sci Monit       Date:  2014-01-07

Review 3.  Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease.

Authors:  Sinee Disthabanchong; Sarinya Boongird
Journal:  World J Nephrol       Date:  2017-05-06

4.  Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: systematic review and meta-analysis of cohort studies.

Authors:  Panayiotis Kouis; Andreas Kousios; Athina Kanari; Daphne Kleopa; Stephania I Papatheodorou; Andrie G Panayiotou
Journal:  Clin Kidney J       Date:  2019-08-28

Review 5.  Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication.

Authors:  Jin Sug Kim; Hyeon Seok Hwang
Journal:  Korean Circ J       Date:  2021-12       Impact factor: 3.243

6.  Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study.

Authors:  Masaru Nakayama; Yoshiki Kaizu; Masaharu Nagata; Yoriko Ura; Hirofumi Ikeda; Sho Shimamoto; Kazuyoshi Kuma
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

7.  Frequency of Specific Cardiovascular Disease Risk Factors among Cameroonian Patients on Dialysis: The Cases of Anaemia, Inflammation, Phosphate, and Calcium.

Authors:  Olivier Pancha Mbouemboue; Olivier Djile Danbe; Marcel Tangyi Tamanji; Jacques Olivier Ngoufack
Journal:  Cardiol Res Pract       Date:  2016-05-22       Impact factor: 1.866

8.  Regulation of vascular smooth muscle cell calcification by syndecan-4/FGF-2/PKCα signalling and cross-talk with TGFβ.

Authors:  Samantha J Borland; Thomas G Morris; Shona C Borland; Mark R Morgan; Sheila E Francis; Catherine L R Merry; Ann E Canfield
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.